Social media and its regulation in pharmacy: what students think
An MPharm student research project was carried out at the school of pharmacy at Keele University to explore students’ familiarity with current social media guidance and to raise awareness of the guidance set out by the Royal Pharmaceutical Society (RPS) (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 29, 2018 Category: Drugs & Pharmacology Source Type: research
Insulin degludec significantly improves blood sugar control compared with insulin glargine, data show
Using electronic health record data, researchers found that HbA1c levels declined by 1.5% among insulin degludec-treated patients compared with 1.2% in those treated with insulin glargine U300 over six months. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 29, 2018 Category: Drugs & Pharmacology Source Type: research
Glucose-lowering therapy does not slow progression in young people with type 2 diabetes
Treatment with glucose-lowering therapy does not maintain or improve pancreatic beta-cell function in young people recently diagnosed with impaired glucose tolerance or type 2 diabetes mellitus, a study has shown. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 17, 2018 Category: Drugs & Pharmacology Source Type: research
Direct oral anticoagulants carry lower risk of major bleeding versus warfarin, data show
Research from primary care suggests apixaban may be the safest of the direct oral anticoagulants overall. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 13, 2018 Category: Drugs & Pharmacology Source Type: research
Gabapentinoids ineffective for lower back pain, review finds
A review published in the Canadian Medical Association Journal has backed up guidance stating that anticonvulsants are ineffective for treating lower back pain. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 10, 2018 Category: Drugs & Pharmacology Source Type: research
Parkinson ’s disease: management and guidance
An overview of Parkinson ’s disease management, including discussion of the updated National Institute for Health and Care Excellence guidelines. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 9, 2018 Category: Drugs & Pharmacology Source Type: research
Impulse-control disorders common in Parkinson ’s patients taking dopamine agonists
Researchers find that after five years of follow-up, more than half of people taking dopamine agonists for management of Parkinson ’s disease developed impulse-control disorders. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 8, 2018 Category: Drugs & Pharmacology Source Type: research
A failure to learn from our mistakes puts patients at risk
Collective amnesia in the NHS means that major issues affecting patient safety, such as medication errors, are not being adequately addressed, writes David Cousins. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 8, 2018 Category: Drugs & Pharmacology Source Type: research
Identifying modifiable risk factors to reduce inpatient hypoglycaemia
Through analysing a randomly selected sample of patients with low blood glucose and diabetes over a course of a year, this prospective study found that a significant number of hypoglycaemia episodes were not treated to established protocol. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 7, 2018 Category: Drugs & Pharmacology Source Type: research
The clinical responses and modifiable risk factors of inpatient hypoglycaemia
Through analysing a randomly selected sample of patients with low blood glucose and diabetes over a course of a year, this prospective study found that a significant number of hypoglycaemia episodes were not treated to established protocol. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 7, 2018 Category: Drugs & Pharmacology Source Type: research
Access to personalised cardiovascular risk information boosts lifestyle change
Research has shown that giving patients personalised information about their disease risk can motivate them to make lifestyle changes. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 6, 2018 Category: Drugs & Pharmacology Source Type: research
Testing annual asthma reviews for those who fail to attend: proof-of-concept study
Asthma is one of the most common respiratory conditions in the UK. Around 30% of asthma patients fail to attend their annual asthma review, which leads to an increase in the number of preventable asthma-related hospital admissions. By using SIMPLE methodology and the PharmOutcomes ® web-based system on 27 patients, it was determined that the community pharmacy asthma review service would enhance patient care through close collaboration with GP surgeries. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 3, 2018 Category: Drugs & Pharmacology Source Type: research
Metronidazole: high dose and long duration risks peripheral neuropathy
Metronidazole — a member of the nitroimidazole class of antibiotics — provides potent bactericidal action against anaerobic bacterial and protozoal infections. It is commonly used across all healthcare settings for common infections and plays an important role in treating confirmed or suspected anaerobic bact erial infections; it is typically associated with deep-seated infections. Combination therapy with penicillin is common and is likely to feature more prominently in hospital formularies ... (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 2, 2018 Category: Drugs & Pharmacology Source Type: research
Pembrolizumab effective in some men with advanced prostate cancer
A study of 258 men with otherwise untreatable prostate cancer shows that the rate of disease control or response lasting six months or more was 11%, with two patients showing complete response. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - August 1, 2018 Category: Drugs & Pharmacology Source Type: research
Sleep disruption linked to atrial fibrillation risk
Sleep disruption is an important risk factor for developing atrial fibrillation, study results show. (Source: Clinical Pharmacist)
Source: Clinical Pharmacist - July 30, 2018 Category: Drugs & Pharmacology Source Type: research
